The Latest Cardiac and Vascular News
AUDUBON, Pa., Nov. 20, 2025 /PRNewswire/ — AIROS® Medical., Inc., a leading medical technology manufacturer and designer specializing in compression therapy devices that treat lymphedema and venous disorders, today announced the release of the AIROS Medical Travel Case. The case will…
From radiology and cardiology to digital pathology and multi-specialty imaging, Hyland enables a single, secure, and interoperable imaging record that enhances clinical decision-making CLEVELAND , Nov. 20, 2025 /PRNewswire/ — Hyland, the pioneer of the Content Innovation Cloud™, will be…
FORT MILL, S.C., Nov. 20, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, today announces the rapid commercial uptake of its LockeT closure device in South Africa.
ALISO VIEJO, Calif., Nov. 19, 2025 /PRNewswire/ — Okami Medical, a medical technology company pioneering novel vascular embolization solutions, today announced the successful close of an oversubscribed $45M financing led by new investor Gilde Healthcare with participation from existing…
The second issue of the open-access journal showcases multidisciplinary heart failure research and the many intersections that shape patient care. WASHINGTON, Nov. 19, 2025 /PRNewswire/ — The second issue of the Journal of Cardiac Failure-Intersections, online now, delivers a diverse…
Accelerating early detection, reducing clinician burden, and enhancing patient outcomes New York, November 18 2025: Qure.ai, a TIME100 most influential company and global leader in digital healthcare, today announced its collaboration with Microsoft. Qure.ai will onboard its end-to-end lung cancer detection, measurement and management suite of AI-powered solutions onto […]
AI-driven innovations in digital health and imaging were discussed at the VEITH Symposium, where Frank Veith and Rasit Dinc evaluated the impact of next-generation technologies on vascular treatments NEW YORK, Nov. 19, 2025 /PRNewswire-PRWeb/ — During a special session at the 52nd annual…
BEDFORD, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) — Spryte Medical, a pioneer in intravascular neuro imaging, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate the INSYTE pivotal trial. The trial will evaluate the safety and effectiveness of Spryte’s neuro Optical Coherence Tomography (nOCT) imaging system for use during intracranial aneurysm treatment procedures.
MONTREAL, Nov. 19, 2025 /PRNewswire/ – Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, cardiometabolic diseases, and cardiomyopathies, today announced…
